Post-earnings recap
Reported
Mon, Nov 9, 2020
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a loss per share of $0.23, which was significantly below expectations. The stock reacted negatively, dropping 7.58% following the announcement. The lack of revenue figures and management commentary adds uncertainty to the company's outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.23 | N/A | -318.18% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.